74 related articles for article (PubMed ID: 22168970)
1. Effect of valproic acid on the outcome of glioblastoma multiforme.
Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
[TBL] [Abstract][Full Text] [Related]
2. Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic.
Shabason JE; Tofilon PJ; Camphausen K
J Cell Mol Med; 2011 Dec; 15(12):2735-44. PubMed ID: 21362133
[TBL] [Abstract][Full Text] [Related]
3. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid use during radiation therapy for glioblastoma associated with improved survival.
Barker CA; Bishop AJ; Chang M; Beal K; Chan TA
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):504-9. PubMed ID: 23523186
[TBL] [Abstract][Full Text] [Related]
5. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme.
Guthrie GD; Eljamel S
J Neurosurg; 2013 Apr; 118(4):859-65. PubMed ID: 23176328
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.
Berendsen S; Broekman M; Seute T; Snijders T; van Es C; de Vos F; Regli L; Robe P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1391-415. PubMed ID: 22668241
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review.
Yuan Y; Xiang W; Qing M; Yanhui L; Jiewen L; Yunhe M
Seizure; 2014 Nov; 23(10):830-5. PubMed ID: 25066904
[TBL] [Abstract][Full Text] [Related]
8. Does the choice of antiepileptic drug have an impact on the survival of glioblastoma multiforme?
Guthrie G; Eljamel S
Br J Neurosurg; 2013 Apr; 27(2):270. PubMed ID: 23472621
[No Abstract] [Full Text] [Related]
9. Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study.
Tinchon A; Oberndorfer S; Marosi C; Gleiss A; Geroldinger A; Sax C; Sherif C; Moser W; Grisold W
J Neurol; 2015 Jan; 262(1):179-86. PubMed ID: 25359262
[TBL] [Abstract][Full Text] [Related]
10. HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme.
Herranz M; Padín-Iruegas ME; Martínez-Lago N; Losada SA; Raña-Díez P; Vázquez EB; Carrera JJ; Antúnez JR; Ruibal A; López-López R
Mol Neurobiol; 2016 Apr; 53(3):1802-1807. PubMed ID: 25752997
[TBL] [Abstract][Full Text] [Related]
11. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation.
Chie EK; Shin JH; Kim JH; Kim HJ; Kim IA; Kim IH
Cancer Res Treat; 2015 Jul; 47(3):527-33. PubMed ID: 25600060
[TBL] [Abstract][Full Text] [Related]
13. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.
Alvarez AA; Field M; Bushnev S; Longo MS; Sugaya K
J Mol Neurosci; 2015 Jan; 55(1):7-20. PubMed ID: 24874578
[TBL] [Abstract][Full Text] [Related]
14. Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors.
Asklund T; Kvarnbrink S; Holmlund C; Wibom C; Bergenheim T; Henriksson R; Hedman H
Anticancer Res; 2012 Jul; 32(7):2407-13. PubMed ID: 22753697
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines.
Barciszewska AM; Belter A; Gawrońska I; Giel-Pietraszuk M; Naskręt-Barciszewska MZ
Front Oncol; 2022; 12():1033035. PubMed ID: 36465345
[TBL] [Abstract][Full Text] [Related]
17. Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53-PUMA Apoptosis Pathway.
Tsai HC; Wei KC; Chen PY; Huang CY; Chen KT; Lin YJ; Cheng HW; Chen YR; Wang HT
Front Oncol; 2021; 11():722754. PubMed ID: 34660288
[TBL] [Abstract][Full Text] [Related]
18. How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis.
Jabbarli R; Ahmadipour Y; Rauschenbach L; Santos AN; Darkwah Oppong M; Pierscianek D; Quesada CM; Kebir S; Dammann P; Guberina N; Scheffler B; Kaier K; Stuschke M; Sure U; Wrede KH
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359673
[TBL] [Abstract][Full Text] [Related]
19. Drugs and Epigenetic Molecular Functions. A Pharmacological Data Scientometric Analysis.
Kringel D; Malkusch S; Lötsch J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298869
[TBL] [Abstract][Full Text] [Related]
20. SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
Walbert T; Harrison RA; Schiff D; Avila EK; Chen M; Kandula P; Lee JW; Le Rhun E; Stevens GHJ; Vogelbaum MA; Wick W; Weller M; Wen PY; Gerstner ER
Neuro Oncol; 2021 Nov; 23(11):1835-1844. PubMed ID: 34174071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
